📊 ECOR Key Takeaways
Is electroCore, Inc. (ECOR) a Good Investment?
electroCore is a pre-revenue profitability company with severe financial distress despite strong gross margins. Negative stockholders' equity of -$1.7M, substantial operating losses of -$13.2M, and negative free cash flow of -$8.3M indicate the company is burning cash faster than it can generate it. While 27.2% revenue growth is notable, it is insufficient to offset mounting operational inefficiencies and the company's unsustainable burn rate.
electroCore is delivering solid top-line growth and exceptionally high gross margins, which suggests the underlying product economics and commercial traction are improving. However, the business remains deeply unprofitable, is burning cash, and has negative stockholders' equity, indicating that balance sheet stress and funding risk still outweigh the revenue momentum. Until operating losses narrow materially and cash generation improves, the fundamentals remain weak.
Why Buy electroCore, Inc. Stock? ECOR Key Strengths
- Strong gross margin of 86.8% demonstrates pricing power and product-market acceptance
- Revenue growth of 27.2% YoY indicates market traction in medical device segment
- Adequate short-term liquidity with current ratio of 1.38x and $7.0M cash reserves
- Revenue grew 27.2% YoY, showing meaningful commercial expansion
- Gross margin of 86.8% indicates strong unit economics and pricing power
- Liquidity is still manageable near term with a 1.38x current ratio and $7.04M in cash
ECOR Stock Risks: electroCore, Inc. Investment Risks
- Negative stockholders' equity of -$1.7M signals insolvency risk and threatens equity holders
- Operating cash flow of -$8.2M with free cash flow margin of -25.8% indicates unsustainable business model
- Total liabilities ($20.4M) exceed total assets ($18.7M) by $1.7M, creating structural balance sheet distress
- Operating margin of -41.1% and net margin of -43.6% demonstrate inability to convert revenue to profitability at scale
- Operating margin of -41.1% and net margin of -43.6% show the business model is not yet self-sustaining
- Negative stockholders' equity and liabilities above assets signal a stressed balance sheet
- Negative free cash flow of -$8.25M raises the risk of future capital needs or dilution
Key Metrics to Watch
- Quarterly operating cash flow trend - critical for assessing path to sustainability
- Gross margin trajectory - must remain elevated to justify continued operations
- Quarterly revenue growth rate - deceleration would accelerate path to capital requirement
- Operating cash burn and free cash flow trend
- Progress in operating margin and path to breakeven
electroCore, Inc. (ECOR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
electroCore, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
ECOR Profit Margin, ROE & Profitability Analysis
ECOR vs Healthcare Sector: How electroCore, Inc. Compares
How electroCore, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is electroCore, Inc. Stock Overvalued? ECOR Valuation Analysis 2026
Based on fundamental analysis, electroCore, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
electroCore, Inc. Balance Sheet: ECOR Debt, Cash & Liquidity
ECOR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: electroCore, Inc.'s revenue has grown significantly by 488% over the 5-year period, indicating strong business expansion. The most recent EPS of $-1.59 indicates the company is currently unprofitable.
ECOR Revenue Growth, EPS Growth & YoY Performance
ECOR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $6.6M | -$2.5M | $-0.31 |
| Q2 2025 | $6.1M | -$2.7M | $-0.38 |
| Q1 2025 | $5.4M | -$3.5M | $-0.47 |
| Q3 2024 | $4.5M | -$2.5M | $-0.31 |
| Q2 2024 | $3.6M | -$2.7M | $-0.38 |
| Q1 2024 | $2.8M | -$3.5M | $-0.53 |
| Q3 2023 | $2.0M | -$4.0M | $-0.68 |
| Q2 2023 | $2.2M | -$4.9M | $-1.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
electroCore, Inc. Dividends, Buybacks & Capital Allocation
ECOR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for electroCore, Inc. (CIK: 0001560258)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ECOR
What is the AI rating for ECOR?
electroCore, Inc. (ECOR) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 88% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ECOR's key strengths?
Claude: Strong gross margin of 86.8% demonstrates pricing power and product-market acceptance. Revenue growth of 27.2% YoY indicates market traction in medical device segment. ChatGPT: Revenue grew 27.2% YoY, showing meaningful commercial expansion. Gross margin of 86.8% indicates strong unit economics and pricing power.
What are the risks of investing in ECOR?
Claude: Negative stockholders' equity of -$1.7M signals insolvency risk and threatens equity holders. Operating cash flow of -$8.2M with free cash flow margin of -25.8% indicates unsustainable business model. ChatGPT: Operating margin of -41.1% and net margin of -43.6% show the business model is not yet self-sustaining. Negative stockholders' equity and liabilities above assets signal a stressed balance sheet.
What is ECOR's revenue and growth?
electroCore, Inc. reported revenue of $32.0M.
Does ECOR pay dividends?
electroCore, Inc. does not currently pay dividends.
Where can I find ECOR SEC filings?
Official SEC filings for electroCore, Inc. (CIK: 0001560258) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ECOR's EPS?
electroCore, Inc. has a diluted EPS of $-1.65.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ECOR a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, electroCore, Inc. has a SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ECOR stock overvalued or undervalued?
Valuation metrics for ECOR: ROE of N/A (sector avg: 15%), net margin of -43.6% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ECOR stock in 2026?
Our dual AI analysis gives electroCore, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ECOR's free cash flow?
electroCore, Inc.'s operating cash flow is $-8.2M, with capital expenditures of $66.0K. FCF margin is -25.8%.
How does ECOR compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -43.6% (avg: 12%), ROE N/A (avg: 15%), current ratio 1.38 (avg: 2).